Sort
25,944 grants matching “neurodegeneration”
Connecting TDP-43 Pathology to the Molecular Profiles of Neurodegeneration
$2,609,330Molly Gale Hammell · Cold Spring Harbor Laboratory · RF1 · FY2020 · NS
Mitochondrial transport and energy metabolism in synaptic transmission and neuronal degeneration and regeneration
$2,608,925Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study
$2,608,673Reisa A. Sperling · Brigham And Women'S Hospital · R01 · FY2024 · AG
Alzheimer's Disease Research Center
$2,605,095Leon J Thal · University Of California, San Diego · P50 · FY2006 · AG
A role for mitochondrial AMPK signaling in neurons
$2,602,940Tommy L Lewis · Oklahoma Medical Research Foundation · RF1 · FY2025 · AG
From therapeutic mechanisms to unraveling the pathophysiology of MS
$2,599,267Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Functional Imaging of The Brain
$2,594,941Alan Koretsky · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Defining the Role of Poly ADP-ribose in Biomolecular Condensation in ALS and FTLD
$2,593,144Sua Myong · Johns Hopkins University · RF1 · FY2020 · AG
Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease
$2,591,567Xiangmin Xu · University Of California-Irvine · U01 · FY2025 · AG
Neurovascular and metabolic sex differences in contributions to cognitive impairment and dementia including Alzheimer's disease
$2,581,762Bistra Iordanova · University Of Pittsburgh At Pittsburgh · RF1 · FY2020 · NS
Pathobiology of Neurodegeneration in C9ORF72 repeat expansion
$2,581,235Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2024 · NS
Can Rapamycin Retard Age-Related Diseases?
$2,576,662Arlan G. Richardson · University Of Texas Hlth Science Center · RC2 · FY2009 · AG
Investigating the Role and the therapeutic potential of Perlecan in experimental vascular dementia
$2,573,724Gregory Jaye Bix · Tulane University Of Louisiana · RF1 · FY2024 · NS
Cell Type and Circuit Mechanisms of Non-Invasive Brain Stimulation by Sensory Entrainment
$2,572,017Anton Arkhipov · Allen Institute · R01 · FY2021 · NS
Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease
$2,566,363Jessica Alber · University Of Rhode Island · R01 · FY2022 · AG
EFFECT OF SPACE RADIATION ON INNATE IMMUNE SYSTEM HOMEOSTASIS DRIVES IMMUNE AND ENDOTHELIAL CELL DYSFUNCTION AND NEURODEGENERATION
$2,556,660University Of Rochester · · FY2021 · National Aeronautics and Space Administration
Regulation of ER-stress Activated UPR kinase PERK in Neurodegenerative Diseases
$2,555,390James D Lechleiter · University Of Texas Hlth Science Center · RF1 · FY2019 · AG
Degenerative and Dementing Diseases of Aging
$2,545,642Stanley B Prusiner · University Of California, San Francisco · P01 · FY2008 · AG
Cognate microglia-neuron interaction and its role in inflammation
$2,542,500Anne Schaefer · Icahn School Of Medicine At Mount Sinai · DP2 · FY2012 · MH
Decoding ribosome-triggered quality control mechanisms
$2,542,500Sichen Shao · Harvard Medical School · DP2 · FY2019 · GM
Multicultural Community Dementia Screening
$2,541,385James E Galvin · University Of Miami School Of Medicine · R01 · FY2025 · AG
KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology
$2,536,396Andrew J Saykin · Indiana University Indianapolis · U01 · FY2022 · AG
Proteostasis in Aging and Neurodegenerative Disease
$2,534,106Richard I. Morimoto · Northwestern University · P01 · FY2019 · AG
Functional analysis of glia in tauopathy
$2,531,613Mel B Feany · Brigham And Women'S Hospital · RF1 · FY2022 · AG
Treatment of OSA on sleep-dependent memory and blood biomarkers in blacks
$2,531,399Korey Kam · Icahn School Of Medicine At Mount Sinai · RF1 · FY2023 · AG